{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:42:47Z","timestamp":1767706967033,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stichting de Merel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A congenital melanocytic naevus (CMN) is a rare skin condition that can be associated with abnormalities of the central nervous system (CNS). These anomalies can sometimes cause severe complications, and rarely death. Adequate information about aetiology and management is therefore crucial. To identify how to monitor patients with CMN, we aimed to estimate the prevalence of neurological involvement in patients with CMN and to summarize what specific neurological signs and symptoms and MRI abnormalities are reported in the medical literature. In addition, we summarized and evaluated the recommendations regarding MRI-screening reported in the medical literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This review was registered in PROSPERO and reported according to the MOOSE checklist. A search was conducted in EMBASE (Ovid), PubMed, and the Cochrane Library. We included studies with 10 or more patients with CMN, reporting on neurological signs and symptoms or CNS MRI. Study selection, data extraction and methodological quality assessment were performed by two independent reviewers. A meta-analysis was used to assess the prevalence of neurological signs and symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 1287 studies, fourteen studies were eligible for inclusion of which eight were included in the meta-analysis<jats:bold>.<\/jats:bold> Neurological signs and symptoms prevalence was 7.04% (CI 95% 4.47\u201310.93%) in the meta-analysis group and 6.26% (95% CI 3.85\u201310%) in a subgroup of patients with a CMN\u2009&gt;\u20096\u00a0cm, evaluated in seven studies. Neurodevelopmental delay and seizures were the most frequently reported signs and symptoms. CNS melanocytosis and hydrocephalus were the most frequently reported MRI abnormalities. It was not possible to estimate the increased risk of neurological involvement in patients with CMN due to low quality of evidence and clinical heterogeneity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Standardization in CMN studies and a multi-centre prospective study are needed to evaluate neurological involvement. Based on current literature, it is not possible to make strong recommendations on routine MRI-screening. For now, every clinical centre should decide on its own policy and weigh the advantages and disadvantages of routine MRI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02234-8","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:03:14Z","timestamp":1646218994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-6468","authenticated-orcid":false,"given":"Anne C.","family":"Fledderus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Linn","family":"Widdershoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corstiaan C.","family":"Breugem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne G. M. A.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal M. A. M.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M.","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis I.","family":"Spuls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"2234_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/0190-9622(91)70115-I","volume":"24","author":"JN Kadonaga","year":"1991","unstructured":"Kadonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991;24:747\u201355.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archderm.1980.01640330055011","volume":"116","author":"LM Solomon","year":"1980","unstructured":"Solomon LM. The management of congenital melanocytic nevi. Arch Dermatol. 1980;116:1017\u20131017.","journal-title":"Arch Dermatol"},{"key":"2234_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1365-2230.2000.00712.x","volume":"25","author":"HM Koot","year":"2000","unstructured":"Koot HM, De Waard-van der Spek F, Peer CD, Mulder PG, Oranje AP. Psychosocial sequelae in 29 children with giant congenital melanocytic naevi. Clin Exp Dermatol. 2000;25:589\u201393.","journal-title":"Clin Exp Dermatol"},{"key":"2234_CR4","first-page":"347","volume":"108","author":"H Hamm","year":"2011","unstructured":"Hamm H, Hoger PH. Skin tumors in childhood. Dtsch Arztebl Int. 2011;108:347\u201353.","journal-title":"Dtsch Arztebl Int"},{"key":"2234_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2133.2008.08775.x","volume":"159","author":"V Kinsler","year":"2008","unstructured":"Kinsler V, Chong W, Aylett S, Atherton DJ. Complications of congenital melanocytic naevi in children: analysis of 16 years\u2019 experience and clinical practice. Br J Dermatol. 2008;159:907\u201314.","journal-title":"Br J Dermatol"},{"key":"2234_CR6","unstructured":"What is a CMN. https:\/\/www.naevusinternational.com\/what-is-cmn\/#1556286821105-3718b811-9a6d. Accessed 19 Oct 2021."},{"key":"2234_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjd.13898","volume":"173","author":"R Waelchli","year":"2015","unstructured":"Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA. Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol. 2015;173:739\u201350.","journal-title":"Br J Dermatol"},{"key":"2234_CR8","unstructured":"Pasmans S, Eggen C, Bergman W, Kukutsch N, Wolkerstorfer A, Stadhouders-keet S, et al. Multidisciplinaire Richtlijn Congenitale Melanocytaire Naevi. https:\/\/www.huidhuis.nl\/sites\/huidhuis.nl\/files\/inline-images\/PDF\/Definitieve%20richtlijn%20CMN.pdf (2017). Accessed 19 Oct 2021."},{"key":"2234_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/00006534-200104010-00005","volume":"107","author":"RD Foster","year":"2001","unstructured":"Foster RD, Williams ML, Barkovich AJ, Hoffman WY, Mathes SJ, Frieden IJ. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg. 2001;107:933\u201341.","journal-title":"Plast Reconstr Surg"},{"key":"2234_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006\u201312.","journal-title":"J Clin Epidemiol"},{"key":"2234_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147\u201353.","journal-title":"Int J Evid Based Healthc"},{"key":"2234_CR12","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630.","journal-title":"BMJ"},{"key":"2234_CR13","unstructured":"OCEBM Levels of Evidence Working Group*. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. https:\/\/www.cebm.net\/wpcontent\/uploads\/2014\/06\/CEBM-Levels-of-Evidence-2.1.pdf. Accessed 19 Oct 2021."},{"key":"2234_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bjps.2019.11.023","volume":"73","author":"A Fledderus","year":"2020","unstructured":"Fledderus A, Franke C, Eggen C, van Etten-Jamaludin FS, van der Horst CMAM, Brinkmann SJH, et al. Outcomes and measurement instruments used in Congenital Melanocytic Naevi research: a systematic review. J Plast Reconstr Aesthet Surg. 2020;73:703\u201315.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2234_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"2234_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, et al. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley; 2019."},{"key":"2234_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000245713","volume":"195","author":"R Ruiz-Maldonado","year":"1997","unstructured":"Ruiz-Maldonado R, del Rosario B-M, Hidalgo-Galvan LR, Medina-Crespo V, Duran-Mckinster C, Tamayo-Sanchez L, et al. Giant congenital melanocytic nevi, neurocutaneous melanosis and neurological alterations. Dermatology. 1997;195:125\u20138.","journal-title":"Dermatology"},{"key":"2234_CR18","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s00247-018-4205-x","volume":"48","author":"K Jakchairoongruang","year":"2018","unstructured":"Jakchairoongruang K, Khakoo Y, Beckwith M, Barkovich AJ. New insights into neurocutaneous melanosis. Pediatr Radiol. 2018;48:1786\u201396.","journal-title":"Pediatr Radiol"},{"key":"2234_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1469-8749.2012.04275.x","volume":"54","author":"V Ramaswamy","year":"2012","unstructured":"Ramaswamy V, Delaney H, Haque S, Marghoob A, Khakoo Y. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Dev Med Child Neurol. 2012;54:563\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"2234_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jaad.2008.11.022","volume":"61","author":"A Lovett","year":"2009","unstructured":"Lovett A, Maari C, Decarie JC, Marcoux D, McCuaig C, Hatami A, et al. Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center\u2019s experience. J Am Acad Dermatol. 2009;61:766\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000488687","volume":"80","author":"M Qian","year":"2018","unstructured":"Qian M, Ren H, Qu T, Lu Z, Zou Y, He J, et al. Spectrum of clinical, neuroimaging, and cerebrospinal fluid features of adult neurocutaneous melanocytosis. Eur Neurol. 2018;80:1\u20136.","journal-title":"Eur Neurol"},{"key":"2234_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/B978-0-444-62702-5.00007-X","volume":"132","author":"MP Islam","year":"2015","unstructured":"Islam MP. Neurocutaneous melanosis. Handb Clin Neurol. 2015;132:111\u20137.","journal-title":"Handb Clin Neurol"},{"key":"2234_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1542\/peds.106.4.736","volume":"106","author":"FV Bittencourt","year":"2000","unstructured":"Bittencourt FV, Marghoob AA, Kopf AW, Koenig KL, Bart RS. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics. 2000;106:736\u201341.","journal-title":"Pediatrics"},{"key":"2234_CR24","first-page":"159","volume":"15","author":"EM Wramp","year":"2017","unstructured":"Wramp EM, Langenbruch A, Augustin M, Zillikens D, Krengel S. Clinical course, treatment modalities, and quality of life in patients with congenital melanocytic nevi-data from the German CMN registry. J Dtsch Dermatol Ges. 2017;15:159\u201367.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2234_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaad.2006.02.063","volume":"54","author":"YC Chan","year":"2006","unstructured":"Chan YC, Giam YC. A retrospective cohort study of Southeast Asian patients with large congenital melanocytic nevi and the risk of melanoma development. J Am Acad Dermatol. 2006;54:778\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1528-1157.1991.tb04675.x","volume":"32","author":"WA Hauser","year":"1991","unstructured":"Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940\u20131980. Epilepsia. 1991;32:429\u201345.","journal-title":"Epilepsia"},{"key":"2234_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1542\/peds.2010-1371","volume":"129","author":"SA Russ","year":"2012","unstructured":"Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129:256\u201364.","journal-title":"Pediatrics"},{"key":"2234_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1528-1157.1997.tb01140.x","volume":"38","author":"DR Nordli Jr","year":"1997","unstructured":"Nordli DR Jr, Bazil CW, Scheuer ML, Pedley TA. Recognition and classification of seizures in infants. Epilepsia. 1997;38:553\u201360.","journal-title":"Epilepsia"},{"key":"2234_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1528-1167.2006.00477.x","volume":"47","author":"E Oka","year":"2006","unstructured":"Oka E, Ohtsuka Y, Yoshinaga H, Murakami N, Kobayashi K, Ogino T. Prevalence of childhood epilepsy and distribution of epileptic syndromes: a population-based survey in Okayama, Japan. Epilepsia. 2006;47:626\u201330.","journal-title":"Epilepsia"},{"key":"2234_CR30","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMc1710724","volume":"377","author":"PR Jansen","year":"2017","unstructured":"Jansen PR, Dremmen M, Van Den Berg A, Dekker IA, Blanken LME, Muetzel RL, et al. Incidental findings on brain imaging in the general pediatric population. N Engl J Med. 2017;377:1593.","journal-title":"N Engl J Med"},{"key":"2234_CR31","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","volume":"357","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821\u20138.","journal-title":"N Engl J Med"},{"key":"2234_CR32","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0140-6736(13)60498-5","volume":"381","author":"VA Kinsler","year":"2013","unstructured":"Kinsler VA, Thomas AC, Ishida M. Congenital melanocytic naevus syndrome is caused by a post-zygotic mutation in codon 61 of NRAS, predisposing to melanoma development in affected tissues. Lancet. 2013;381:S58.","journal-title":"Lancet"},{"key":"2234_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/jid.2013.531","volume":"134","author":"HC Etchevers","year":"2014","unstructured":"Etchevers HC. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi. J Invest Dermatol. 2014;134:879\u201382.","journal-title":"J Invest Dermatol"},{"key":"2234_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/B978-0-444-52891-9.00042-7","volume":"111","author":"L Flores-Sarnat","year":"2013","unstructured":"Flores-Sarnat L. Neurocutaneous melanocytosis. Handb Clin Neurol. 2013;111:369\u201388.","journal-title":"Handb Clin Neurol"},{"key":"2234_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1525-1470.1992.tb00323.x","volume":"9","author":"JN Kadonaga","year":"1992","unstructured":"Kadonaga JN, Barkovich AJ, Edwards MS, Frieden IJ. Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol. 1992;9:37\u201343.","journal-title":"Pediatr Dermatol"},{"key":"2234_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/BF00607285","volume":"38","author":"J Chaloupka","year":"1996","unstructured":"Chaloupka J, Wolf R, Varma P. Neurocutaneous melanosis with the Dandy-Walker malformation: a possible rare pathoetiologic association. Neuroradiology. 1996;38:486\u20139.","journal-title":"Neuroradiology"},{"key":"2234_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0190-9622(98)70264-6","volume":"39","author":"CL Egan","year":"1998","unstructured":"Egan CL, Oliveria SA, Elenitsas R, Hanson J, Halpern AC. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol. 1998;39:923\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2133.2005.06316.x","volume":"152","author":"EK Hale","year":"2005","unstructured":"Hale EK, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi\u2014results from the NYU\u2013LCMN registry. Br J Dermatol. 2005;152:512\u20137.","journal-title":"Br J Dermatol"},{"key":"2234_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5414\/NP300363","volume":"30","author":"B Sutton","year":"2011","unstructured":"Sutton B, Tatter S, Stanton C, Mott RT. Leptomeningeal melanocytosis in an adult male without large congenital nevi: a rare and atypical case of neurocutaneous melanosis. Clin Neuropathol. 2011;30:178.","journal-title":"Clin Neuropathol"},{"key":"2234_CR40","doi-asserted-by":"publisher","first-page":"E798","DOI":"10.1097\/BRS.0b013e3181808c9a","volume":"33","author":"K Asanuma","year":"2008","unstructured":"Asanuma K, Kasai Y, Takegami K, Haruo I, Yoshikawa T, Uchida A. Spinal neurocutaneous melanosis without cutaneous nevi. Spine. 2008;33:E798\u2013801.","journal-title":"Spine"},{"key":"2234_CR41","first-page":"39","volume":"31","author":"GA van Engen-van","year":"2014","unstructured":"van Engen-van GA, Kusters-Vandevelde H, Groenen P, Blokx W. Update on molecular pathology of cutaneous melanocytic lesions: what is new in diagnosis and molecular testing for treatment? Front Med (Lausanne). 2014;31:39.","journal-title":"Front Med (Lausanne)"},{"key":"2234_CR42","first-page":"178","volume":"60","author":"MA Cruz","year":"1997","unstructured":"Cruz MA, Cho E-S, Schwartz R, Janniger CK. Congenital neurocutaneous melanosis. Cutis. 1997;60:178\u201381.","journal-title":"Cutis"},{"key":"2234_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0190-9622(96)90674-X","volume":"35","author":"M DeDavid","year":"1996","unstructured":"DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Wasti Q, et al. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol. 1996;35:529\u201338.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR44","doi-asserted-by":"publisher","first-page":"107061","DOI":"10.1016\/j.yebeh.2020.107061","volume":"107","author":"G Pellino","year":"2020","unstructured":"Pellino G, Gencarelli J, Bertelli S, Russo A, Fiumana E, Faggioli R. Epilepsy in isolated parenchymal neurocutaneous melanosis: a systematic review. Epilepsy Behav. 2020;107:107061.","journal-title":"Epilepsy Behav"},{"key":"2234_CR45","first-page":"859","volume":"15","author":"A Barkovich","year":"1994","unstructured":"Barkovich A, Frieden I, Williams M. MR of neurocutaneous melanosis. AJNR Am J Neuroradiol. 1994;15:859\u201367.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2234_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjd.13976","volume":"173","author":"S Barbarot","year":"2015","unstructured":"Barbarot S. Revisiting neurocutaneous melanosis spectrum: do we have to undertake systematic magnetic resonance imaging in children with congenital melanocytic naevi? Br J Dermatol. 2015;173:639.","journal-title":"Br J Dermatol"},{"key":"2234_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clinimag.2013.10.001","volume":"38","author":"M Bekiesi\u0144ska-Figatowska","year":"2014","unstructured":"Bekiesi\u0144ska-Figatowska M, Szczygielski O, Boczar M, Madzik J, Klepacka T, Michalak E, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging. 2014;38:79\u201384.","journal-title":"Clin Imaging"},{"key":"2234_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jaad.2005.10.040","volume":"54","author":"BJ Bett","year":"2006","unstructured":"Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons. J Am Acad Dermatol. 2006;54:767\u201377.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1148\/rg.322105761","volume":"32","author":"DT Ginat","year":"2012","unstructured":"Ginat DT, Meyers SP. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics. 2012;32:499\u2013516.","journal-title":"Radiographics"},{"key":"2234_CR50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jaad.2016.05.042","volume":"76","author":"VPM da Silva","year":"2017","unstructured":"da Silva VPM, Marghoob A, Pigem R, Carrera C, Aguilera P, Puig-Butille JA, et al. Patterns of distribution of giant congenital melanocytic nevi (GCMN): the 6B rule. J Am Acad Dermatol. 2017;76:689\u201394.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaad.2012.05.043","volume":"68","author":"S Krengel","year":"2013","unstructured":"Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68:441\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"2234_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bjd.19694","volume":"185","author":"W Oei","year":"2021","unstructured":"Oei W, Fledderus A, Spuls P, Eggen CAM, Kottner J, van der Horst CMAM, et al. Development of an international core domain set for medium, large and giant congenital melanocytic nevi as a first step towards a core outcome set for clinical practice and research. BrJ Dermatol. 2021;185:371\u20139.","journal-title":"BrJ Dermatol"},{"key":"2234_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/jdv.15874","volume":"34","author":"W Oei","year":"2020","unstructured":"Oei W, Fledderus AC, Korfage I, Eggen CAM, van der Horst CMAM, Spuls PI, et al. Protocol for the development of core set of domains of the core outcome set for patients with congenital melanocytic naevi (OCOMEN project). J Eur Acad Dermatol Venereol. 2020;34:267\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"185","key":"2234_CR54","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bjd.20437","volume":"2021","author":"AC Fledderus","year":"2021","unstructured":"Fledderus AC, Pasmans S, Wolkerstorfer A, Oei W, Etchevers HC, van Kessel MS, van der Horst C, Spuls PI. Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research, part 2 (the OCOMEN project). Br J Dermatol. 2021;2021(185):970\u20137.","journal-title":"Br J Dermatol"},{"key":"2234_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/pde.12428","volume":"32","author":"HN Price","year":"2015","unstructured":"Price HN, O\u2019Haver J, Marghoob A, Badger K, Etchevers H, Krengel S. Practical application of the new classification scheme for congenital melanocytic nevi. Pediatr Dermatol. 2015;32:23\u20137.","journal-title":"Pediatr Dermatol"},{"key":"2234_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1590\/abd1806-4841.20175176","volume":"92","author":"ACL Viana","year":"2017","unstructured":"Viana ACL, Goulart EMA, Gontijo B, Bittencourt FV. A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma. An Bras Dermatol. 2017;92:200\u20135.","journal-title":"An Bras Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02234-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02234-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02234-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T04:10:15Z","timestamp":1666411815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02234-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2234"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02234-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"22 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for systematic reviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have stated that they had no interests which might be perceived as posing a conflict or bias. The authors have no other financial or personal relationships relevant to this study to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}